Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OptiMed Technology develops nanotechnology-enabled products such as toothpaste and 3D printed denture materials that deliver therapeutic agents directly within the mouth. Their lead innovations include dentures embedded with microscopic capsules that periodically release antifungal drugs, targeting conditions like fungal infections and gum overgrowth. The company has received grant funding and collaborates closely with academic researchers at the University at Buffalo. Commercialization efforts are underway but no clinical trial results have been published yet.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OptiMed Technology.